Botulinum toxin vs hyaluronic acid injections for knee osteoarthritis
Official title: Intraarticular Injection of Botox and Hyaluronic Acid in Knee Osteoarthritis
Run by Tanta University · NCT07666347 · Data updated 2026-11-12
This study tests whether injecting botulinum toxin or hyaluronic acid directly into the knee provides better pain relief for people with knee osteoarthritis.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 50 Years and up |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Tanta University Academic / other |
| Locations | 1 site (Tanta, El-Gharbia) |
| Status | Recruiting |
| Started | June 24, 2026 |
| Main results expected | December 1, 2026 |
| Study ends | December 1, 2026 |
| Registry record updated | June 25, 2026 |
| Trial ID | NCT07666347 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 50 and older with chronic knee OA (Kellgren-Lawrence grade 3–4) eligible for intra-articular injections.
✕Probably not a fit
Individuals with recent knee injections, significant comorbidities limiting participation, or BMI above 40 kg/m2 may have reduced benefit or be excluded.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study compares two intra-articular injections—botulinum toxin type A and hyaluronic acid—in adults with knee osteoarthritis. Participants are 50 years or older and meet diagnostic criteria with moderate radiographic OA. The trial will assess pain outcomes after treatment to determine which injection offers more pain relief with an acceptable safety profile. The mechanism involves botulinum toxin reducing nerve signaling and hyaluronic acid aiming to improve joint lubrication, with patients followed for a defined period to evaluate efficacy and safety. The study is conducted at Tanta University in Egypt under a lead sponsorship with no listed collaborators.
Why it matters
Potential benefit: If successful, patients could experience better knee pain control from a single IA injection strategy.
How similar studies have gone: Previous research has explored IA hyaluronic acid with mixed results; this direct comparison to botulinum toxin is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 50 years. * Both genders. * Chronic knee osteoarthritis (KOA) according to American College of Rheumatology criteria for the diagnosis of knee osteoarthritis. * Third or fourth grade Kellgren and Lawrence system for classification of osteoarthritis based on radiological data, it is a common method of classifying the severity of osteoarthritis (OA) using five grades according to the following sites and projections. Exclusion Criteria: * History of intra-articular injection within the last 6 months, * History of surgery on the knee joint or major trauma to the lower limb causing fracture. * Body mass index (BMI) more than 40 kg/m2. * Medical conditions affecting the joint or lower extremity function such as severe osteoporosis, rheumatoid arthritis, collagen vascular diseases, and gout. * Diabetic patient. * Any contraindication to intra-articular injections for instance immunodeficiency, coagulation defect or anticoagulation therapy taking or skin infection at the site of injection. * Hypersensitivity to Botulinum toxin or hyaluronic acid.
Where it's running
-
Tanta University
Tanta, El-Gharbia, Egypt Recruiting
Study contacts
- Study coordinator: Mohammed S ElSharkawy, MD
- Email: mselsharkawy@med.tanta.edu.eg
- Phone: 00201148207870
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Hyaluronic acid injections to reduce knee inflammation and improve symptoms
This trial will see if hyaluronic acid knee injections lower inflammatory markers (TNF‑alpha and IL‑1β) and improve pain, function, and quality of life in adults 45–75 with moderate (Kellgren‑Lawrence 2–3) knee osteoarthritis.
-
Combined PRP and hyaluronic acid injections for knee osteoarthritis
This study sees if giving a mix of platelet-rich plasma and hyaluronic acid into the knee helps people with osteoarthritis.
-
Effects of virtual reality on walking in adults with knee osteoarthritis
This study tests how immersive virtual reality environments—designed to feel safe or to provoke fear—affect walking and worry about movement in adults 50 and older with knee osteoarthritis and in healthy peers.
-
Improved Facial Skin Quality After VYC-12L for Breast Cancer Survivors
This study tests whether intradermal injections of VYC-12L can improve facial skin quality and quality of life in adults who have completed breast cancer treatment.
-
Weekly berobenatide for knee osteoarthritis in adults who are overweight or obese
This study tests whether weekly berobenatide helps reduce knee pain and improve function, while also affecting body weight, in adults with knee osteoarthritis who are overweight or obese (with or without type 2 diabetes).
-
Autologous adipose-derived stem cell injections for knee osteoarthritis
We’re testing whether injecting a patient’s own fat-derived stem cells into the knee can help people with knee OA feel less pain and move better, compared with a standard hyaluronic acid treatment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.